Qiurong Ding
Overview
Explore the profile of Qiurong Ding including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
74
Citations
2586
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li S, Jiang D, Li X, Zhao Y, Gu X, Jiang C, et al.
Life Med
. 2025 Jan;
3(4):lnae026.
PMID: 39872867
No abstract available.
2.
Zhou T, Kiran M, Lui K, Ding Q
Life Med
. 2025 Jan;
1(3):333-344.
PMID: 39872749
Liver fibrogenesis is a highly dynamic and complex process that drives the progression of chronic liver disease toward liver failure and end-stage liver diseases. Despite decades of intense studies, the...
3.
Jiang M, Zheng Z, Wang X, Chen Y, Qu J, Ding Q, et al.
Life Med
. 2025 Jan;
3(1):lnae004.
PMID: 39872390
In human aging, liver aging per se not only increases susceptibility to liver diseases but also increases vulnerability of other organs given its central role in regulating metabolism. Total liver...
4.
Chabronova A, Ding Q, Martini M, Nair P
Trends Mol Med
. 2024 Dec;
30(6):517-520.
PMID: 39648583
No abstract available.
5.
Wu X, Jiang D, Wang Y, Li X, Liu C, Chen Y, et al.
Hepatol Commun
. 2024 Dec;
8(12).
PMID: 39621053
Background: Metabolic-associated steatohepatitis (MASH) is one of the most prevalent liver diseases worldwide, with a global prevalence estimated between 3% and 5%, posing a significant health burden. Human liver organoids...
6.
Yuan C, Zhang C, Geng X, Feng C, Su Y, Wu Y, et al.
BMC Public Health
. 2024 Nov;
24(1):3264.
PMID: 39587552
Background: Metabolic dysfunction-associated fatty liver disease (MAFLD) affects up to one-third of the global population. Since no approved pharmacotherapy for MAFLD is available, lifestyle modification remains the cornerstone of clinical...
7.
Huang Y, Yu F, Ding Y, Zhang H, Li X, Wang X, et al.
Hepatology
. 2024 Jul;
PMID: 38985984
Background And Aims: An imbalance in lipid metabolism is the main cause of NAFLD. While the pathogenesis of lipid accumulation mediated by extrahepatic regulators has been extensively studied, the intrahepatic...
8.
Tian C, Gu X, Jiang C, Ding Q
Trends Mol Med
. 2024 Mar;
30(6):527-529.
PMID: 38521716
MORF4 (mortality factor on chromosome 4)-related gene 15 (MRG15) is a chromodomain protein that exists in various multiprotein complexes involved in transcription, DNA repair, and development. Here we summarize the...
9.
Jin J, He Y, Guo J, Pan Q, Wei X, Xu C, et al.
Nat Commun
. 2023 Dec;
14(1):8428.
PMID: 38129407
Hepatic insulin resistance is central to the metabolic syndrome. Here we investigate the role of BTB and CNC homology 1 (BACH1) in hepatic insulin signaling. BACH1 is elevated in the...
10.
Wang L, Zhang X, Zhang H, Lu K, Li M, Li X, et al.
EMBO Rep
. 2023 Nov;
24(12):e57925.
PMID: 37965894
In mammals, the most remarkable T cell variations with aging are the shrinking of the naïve T cell pool and the enlargement of the memory T cell pool, which are...